Eli Lilly EVP Daniel Skovronsky Reports Gift of 119 Shares
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Eli Lilly & Co ($LLY) Form 4 Filing Analysis
Insider: Daniel Skovronsky (EVP, CS&PO & Pres. LRL) Transaction Date: November 2, 2026 Type: Gift (Code G) | Shares: 119 Price: $0.00 | Total Value: $0.00 Direct Shares Remaining: 159,952.725 Indirect Holdings: 75,616 shares (Trust, Spouse, SLAT) Significance: Low
Comprehensive Analysis
Transaction Summary
On November 2, 2026, Daniel Skovronsky, Executive Vice President, Chief Scientific and Product Officer, and President of Lilly Research Laboratories at Eli Lilly & Co ($LLY), reported the disposition of 119 shares of common stock via a bona fide gift (Transaction Code 'G') at $0.00 per share.
Ownership Structure Post-Transaction
Following this transaction, Dr. Skovronsky retains substantial ownership in the company:
- Direct Ownership: 159,952.725 shares
- Indirect Holdings:
- 72,359 shares held by Trust
- 547 shares held by spouse
- 2,710 shares held by spouse's SLAT
Trading Significance Assessment
The transaction is classified as Low Significance. The disposition represents a charitable or personal gift of only 119 shares, comprising a negligible fraction (less than 0.1%) of his total direct and indirect equity holdings exceeding 235,000 shares. Gift transactions do not reflect open-market sentiment or economic positioning.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.